1. Home
  2. INO
  3. INO News

Latest Inovio Pharmaceuticals Inc. (INO) News on April 3, 2025

Down -11.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO)
INO

Zacks

2 days ago

Down -11.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO)

INO

MT Newswires

15 days ago

RBC Cuts Price Target on Inovio Pharmaceuticals to $5 From $6, Keeps Sector Perform, Speculative Risk

Inovio Pharmaceuticals Inc (INO) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
INO

GuruFocus.com

15 days ago

Inovio Pharmaceuticals Inc (INO) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

Inovio Pharmaceuticals (INO) Q4 2024 Earnings Call Transcript
INO

Motley Fool

15 days ago

Inovio Pharmaceuticals (INO) Q4 2024 Earnings Call Transcript

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
INO

PR Newswire

16 days ago

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

INO

MT Newswires

20 days ago

Sector Update: Health Care Stocks Higher Premarket Friday

INO

MT Newswires

20 days ago

Inovio Pharmaceuticals Reports Interim Trial Results of DNA-Encoded Monoclonal Antibodies for COVID-19

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
INO

PR Newswire

20 days ago

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025
INO

PR Newswire

22 days ago

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025

Here's Why Inovio (INO) Could be Great Choice for a Bottom Fisher
INO

Zacks

2 months ago

Here's Why Inovio (INO) Could be Great Choice for a Bottom Fisher

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications
INO

PR Newswire

2 months ago

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
INO

PR Newswire

2 months ago

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
INO

PR Newswire

2 months ago

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments
INO

PR Newswire

3 months ago

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments

INO

MT Newswires

4 months ago

Top Midday Decliners

INO

MT Newswires

4 months ago

Inovio Prices $30 Million Public Offering of Shares, Accompanying Warrants

INOVIO Announces Pricing of $30 Million Public Offering
INO

PR Newswire

4 months ago

INOVIO Announces Pricing of $30 Million Public Offering

INOVIO Announces Proposed Public Offering
INO

PR Newswire

4 months ago

INOVIO Announces Proposed Public Offering

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
INO

PR Newswire

4 months ago

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

INOVIO Reports Inducement Grant Under Inducement Plan
INO

PR Newswire

4 months ago

INOVIO Reports Inducement Grant Under Inducement Plan

INO

MT Newswires

5 months ago

Oppenheimer Adjusts Inovio Pharmaceuticals Price Target to $15 From $33, Maintains Outperform Rating

Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023)
INO

Simply Wall St.

5 months ago

Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023)

INO

MT Newswires

5 months ago

RBC Lowers Price Target on Inovio Pharmaceuticals to $6 From $7, Keeps Sector Perform, Speculative Risk

Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ...
INO

GuruFocus.com

5 months ago

Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ...

Where are they now? 4 biotechs that soared then crashed during the pandemic
INO

Pharma Voice

5 months ago

Where are they now? 4 biotechs that soared then crashed during the pandemic

Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript
INO

Motley Fool

5 months ago

Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript

INO

Associated Press Finance

5 months ago

Inovio: Q3 Earnings Snapshot

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
INO

PR Newswire

5 months ago

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial
INO

PR Newswire

5 months ago

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial

INOVIO to Present at Upcoming Scientific Conferences
INO

PR Newswire

5 months ago

INOVIO to Present at Upcoming Scientific Conferences

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024
INO

PR Newswire

5 months ago

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
INO

PR Newswire

5 months ago

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP

Exelixis (EXEL) Soars 8.6%: Is Further Upside Left in the Stock?
INO

Zacks

6 months ago

Exelixis (EXEL) Soars 8.6%: Is Further Upside Left in the Stock?

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?
INO

Zacks

6 months ago

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?

INO

MT Newswires

6 months ago

RBC Cuts Price Target on Inovio Pharmaceuticals to $7 From $8, Keeps Sector Perform, Speculative Risk

INOVIO Reports Inducement Grants Under Inducement Plan
INO

PR Newswire

6 months ago

INOVIO Reports Inducement Grants Under Inducement Plan

INOVIO to Present at Upcoming Scientific Conferences
INO

PR Newswire

6 months ago

INOVIO to Present at Upcoming Scientific Conferences

INOVIO to Present at Upcoming Scientific Conference
INO

PR Newswire

7 months ago

INOVIO to Present at Upcoming Scientific Conference

We Think Inovio Pharmaceuticals (NASDAQ:INO) Needs To Drive Business Growth Carefully
INO

Simply Wall St.

8 months ago

We Think Inovio Pharmaceuticals (NASDAQ:INO) Needs To Drive Business Growth Carefully

INO

MT Newswires

8 months ago

RBC Cuts Price Target on Inovio Pharmaceuticals to $8 From $11, Keeps Sector Perform, Speculative Risk

Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript
INO

Motley Fool

8 months ago

Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript

INO

Associated Press Finance

8 months ago

Inovio: Q2 Earnings Snapshot

INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights
INO

PR Newswire

8 months ago

INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights

INOVIO Reports Inducement Grant Under Inducement Plan
INO

PR Newswire

8 months ago

INOVIO Reports Inducement Grant Under Inducement Plan

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107
INO

PR Newswire

8 months ago

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024
INO

PR Newswire

8 months ago

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024

Inovio (INO) Up as Lead Drug Gets Innovative Medicine Tag in UK
INO

Zacks

9 months ago

Inovio (INO) Up as Lead Drug Gets Innovative Medicine Tag in UK

Inovio (INO) Soars 19.0%: Is Further Upside Left in the Stock?
INO

Zacks

9 months ago

Inovio (INO) Soars 19.0%: Is Further Upside Left in the Stock?

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway
INO

PR Newswire

9 months ago

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway

INO

MT Newswires

9 months ago

Inovio Pharmaceuticals Names Steven Egge Chief Commercial Officer

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer
INO

PR Newswire

9 months ago

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer

INOVIO Reports Inducement Grant Under Inducement Plan
INO

PR Newswire

9 months ago

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Added to Russell 2000® Index Effective July 1, 2024
INO

PR Newswire

9 months ago

INOVIO Added to Russell 2000® Index Effective July 1, 2024

Lotto 6/49 - $64 million up for grabs in the next draw!
INO

CNW Group

10 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
INO

Simply Wall St.

10 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
INO

AFP

10 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
INO

Simply Wall St.

10 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
INO

Simply Wall St.

10 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
INO

Barrons.com

10 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
INO

Simply Wall St.

10 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
INO

Simply Wall St.

10 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.
INO

PR Newswire

10 months ago

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

INOVIO Reports Inducement Grants Under Inducement Plan
INO

PR Newswire

10 months ago

INOVIO Reports Inducement Grants Under Inducement Plan

Better Buy: Inovio Pharmaceuticals vs. Novavax
INO

Motley Fool

10 months ago

Better Buy: Inovio Pharmaceuticals vs. Novavax

INO

MT Newswires

a year ago

Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target

INO

GuruFocus.com

a year ago

Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
INO

Motley Fool

a year ago

Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript

INO

Associated Press Finance

a year ago

Inovio: Q1 Earnings Snapshot

INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
INO

PR Newswire

a year ago

INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights

This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
INO

Motley Fool

a year ago

This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?

INOVIO Reports Inducement Grants Under Inducement Plan
INO

PR Newswire

a year ago

INOVIO Reports Inducement Grants Under Inducement Plan

INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
INO

PR Newswire

a year ago

INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024

INOVIO to Participate in Upcoming Investor Conferences in May
INO

PR Newswire

a year ago

INOVIO to Participate in Upcoming Investor Conferences in May

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
INO

PR Newswire

a year ago

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
INO

PR Newswire

a year ago

INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine

Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
INO

Zacks

a year ago

Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
INO

Insider Monkey

a year ago

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript

INO

Thomson Reuters StreetEvents

a year ago

Q4 2023 Inovio Pharmaceuticals Inc Earnings Call

Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
INO

Motley Fool

a year ago

Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript

INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
INO

PR Newswire

a year ago

INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
INO

PR Newswire

a year ago

Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Wall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Know
INO

Zacks

a year ago

Wall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Know

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
INO

PR Newswire

a year ago

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024

Inovio (INO) Moves 17.4% Higher: Will This Strength Last?
INO

Zacks

a year ago

Inovio (INO) Moves 17.4% Higher: Will This Strength Last?

INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
INO

PR Newswire

a year ago

INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

INOVIO Reports Inducement Grant Under Inducement Plan
INO

PR Newswire

a year ago

INOVIO Reports Inducement Grant Under Inducement Plan

How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%
INO

Zacks

a year ago

How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%

PlayAGS (AGS) Surges 8.7%: Is This an Indication of Further Gains?
INO

Zacks

a year ago

PlayAGS (AGS) Surges 8.7%: Is This an Indication of Further Gains?

LINKBANCORP, Inc. Announces Fourth Quarter 2023 and Full Year 2023 Financial Results
INO

PR Newswire

a year ago

LINKBANCORP, Inc. Announces Fourth Quarter 2023 and Full Year 2023 Financial Results

SkyWater Technology to Announce Fourth Quarter Financial Results on February 26, 2024
INO

Business Wire

a year ago

SkyWater Technology to Announce Fourth Quarter Financial Results on February 26, 2024

Peoples Financial Services Full Year 2023 Earnings: Misses Expectations
INO

Simply Wall St.

a year ago

Peoples Financial Services Full Year 2023 Earnings: Misses Expectations

Peoples Bancorp (PEBO) Could Be a Great Choice
INO

Zacks

a year ago

Peoples Bancorp (PEBO) Could Be a Great Choice

Media Firms Shine Spotlight on Retaining Customers
INO

Business Wire

a year ago

Media Firms Shine Spotlight on Retaining Customers

Redfin Reports Price Growth Starts the Year Strong But Harsh Weather Freezes Out Some Would-Be Homebuyers
INO

Business Wire

a year ago

Redfin Reports Price Growth Starts the Year Strong But Harsh Weather Freezes Out Some Would-Be Homebuyers

InterDigital Joins Princeton University’s NextG Corporate Program
INO

GlobeNewswire

a year ago

InterDigital Joins Princeton University’s NextG Corporate Program

Colony Bankcorp, Inc. Promotes Derek Shelnutt to Executive Vice President and Chief Financial Officer
INO

Business Wire

a year ago

Colony Bankcorp, Inc. Promotes Derek Shelnutt to Executive Vice President and Chief Financial Officer

INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
INO

PR Newswire

a year ago

INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split

INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
INO

PR Newswire

a year ago

INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader

INO

Business Wire

a year ago

Hope Bancorp to Report 2023 Fourth Quarter Financial Results on Tuesday, January 30, 2024

Star Group LP's Dividend Analysis
INO

GuruFocus.com

a year ago

Star Group LP's Dividend Analysis

Share on Social Networks: